By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GATC Biotech this week said that it intends to analyze 100,000 human genomes within the next four year for pharmaceutical, diagnostic, and academic research customers. The sequencing services provider added that it will open a new business unit for human genome analysis at its headquarters in Germany. GATC said that it will use Illumina's HiSeq 2000 and Pacific Biosciences' RS systems to achieve its goal.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.